Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
AMYPAD announces Last Patient Out in its Prognostic Study
AMYPAD announces Last Patient Out in its Prognostic Study 15 Jul 2022 All PNHS sites have been done with the recruitment and scanning of participants......
AMYPAD at AAIC2022
AMYPAD at AAIC2022 08 Jul 2022 Several AMYPAD researchers will be presenting their respective work at AAIC22......
New AMYPAD paper published in Brain Communications
New AMYPAD paper published in Brain Communications 30 Jun 2022 In this work, authors used data from three parent cohorts involved in the AMYPAD......
Recruitment status (as 30 April 2022)
Recruitment status (as 30 April 2022)